Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.

J Transl Med · 2022 · PMC9172186 · PMID 35672823

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Further evidence of a potential immunotherapeutic role is provided by a strong trend towards more CD26 high tumor-infiltrating lymphocytes (TILs) being observed in patients with oral cavity squamous cell carcinoma who responded to neoadjuvant PD-1 therapy [ 2 , 3 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.